HOME >> BIOLOGY >> NEWS
Purdue, Indiana universities collaborate for better medicine

WEST LAFAYETTE, Ind. -- Purdue University and Indiana University School of Medicine researchers have launched a collaboration to increase knowledge of diseases and develop better treatments for humans and animals.

Scientists from Purdue's schools of Agriculture and Veterinary Medicine and the IU School of Medicine are initiating the Program of Comparative Medicine through a $2 million, two year start-up grant from the Indiana 21st Century Research and Technology Fund. The program has a total of $4.5 million in initial funding due to contributions from the Purdue schools of Agriculture and Veterinary Medicine, the IU School of Medicine Department of Pediatrics and the Indiana Genomics Initiative.

"Much of the work we do at Purdue in both the Department of Animal Sciences and the School of Veterinary Medicine impacts both animal and human health," said Randy Woodson, director of agricultural research and co-author of the proposal that netted the state funding. "Purdue's role is to develop animal models for human diseases that also will provide benefits for improved pet and livestock health and productivity."

IU scientists bring to the program expertise in understanding disease development and treatment, said Dr. Mervin Yoder, an professor of pediatrics, biochemistry and molecular biology at IU.

The researchers believe the best way to understand human disease is to understand similar diseases in other animals, said Yoder, who co-wrote the grant proposal with Woodson.

"By studying multiple species, we'll learn more about diseases and ways to treat them," he said.

The research at Purdue will involve a number of current animal sciences and veterinary medicine faculty members and also researchers in two new positions for which the Department of Animal Sciences is recruiting, said department head Alan Grant.

"This draws on our existing facilities and faculties at both universities and also calls for some renovation o
'"/>

Contact: Susan A. Steeves
ssteeves@purdue.edu
765-496-7481
Purdue University
4-Dec-2002


Page: 1 2 3

Related biology news :

1. Indiana University, EPA to study airborne PCBs
2. As informatics grows, Indiana University helps set research agenda
3. Worlds largest scientific society convenes regional meeting June 2-4 in Indianapolis
4. First descriptions of Indiana bat maternity roosts in the southern US
5. Indiana University to become NASA base for space biology studies
6. Largest grant ever to Indiana U fuels Genomics Initiative
7. By all measurements -- Indianas forests are growing
8. Purdue helps Indiana companies with pollution dilemma
9. Water Quality In Indianas White River Basin Affected By Urban And Agricultural Activities
10. K-State, other universities to study how climate affects plant evolution
11. S.C. hospitals and universities form statewide health research collaborative

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Purdue Indiana universities collaborate for better medicine

(Date:2/13/2015)... 2015 ACT Genomics Co., Ltd., a ... transform cancer genomic information into precision diagnosis and ... raised US$ 8 million in the its first private ... Taipei, Taiwan , ACT Genomics has developed ... aim to implement next generation sequencing (NGS) and ...
(Date:2/12/2015)... Conn. , Feb. 12, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62/113114 for DISTRIBUTED ... DEVICES. The patent further establishes NXT-ID,s position ... its intellectual property portfolio the ability for multiple devices ...
(Date:2/10/2015)... Mass., Feb. 10, 2015  Alere Inc. (NYSE: ... its financial results for the quarter ended December ... Officer and President of Alere said, "We made ... Alere as the global leader in rapid diagnostics ... the Alere Health divestiture in early January enabled ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33
(Date:2/27/2015)... 27, 2015 Immunovaccine Inc. (“Immunovaccine” or ... a fraudulent press release disseminated this morning by PR ... Immunovaccine. This press release states that Immunovaccine has entered ... The press release did not originate from Immunovaccine and ... the press release. Please note that all official ...
(Date:2/27/2015)... Scotia (PRWEB) February 27, 2015 ... vaccine and immunotherapy company, today announced that the ... application for Fast Track designation and Phase I ... in conjunction with the mutual co-development agreement signed ... obtained Fast Track designation for the DPX-Survivac. , ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Cytokinetics, ... forces on February 28 with patients and health care ... awareness for Rare Disease Day®. Rare Disease Day ... and calling attention to the special challenges faced by ... them. , “Cytokinetics is proud to stand alongside patients ...
(Date:2/26/2015)... 2015  23andMe, the leading personal genetics company, today ... Privacy Officer and Corporate Counsel. Black brings a strong ... well as health care regulations. As a member of ... for reviewing, updating and enhancing the company,s privacy and ... She joined the company January 5, 2015 and reports ...
Breaking Biology Technology:Immunovaccine Disclaims Hoax Press Release 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 623andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2
Cached News: